Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SH2scan: Mapping SH2 Domain-Ligand Binding Selectivity for Inhibitors and Degraders. | J Med Chem | 2026 | 41543922 | PubTator, text mining | PubMed |
| Therapeutic horizons in the development of PROTAC-based EZH2 inhibitors: recent achievements, comparative analysis, and future perspectives. | RSC Adv | 2026 | 41541203 | PubTator, text mining | PubMed |
| Allosteric PROTACs: Expanding the Horizon of Targeted Protein Degradation. | J Am Chem Soc | 2026 | 41530095 | PubTator, text mining | PubMed |
| Molecular Mechanisms and Therapeutic Potential of Degron-Mediated Proteostasis Regulation in Neurodegenerative Diseases. | Cell Mol Neurobiol | 2026 | 41528540 | PubTator, text mining | PubMed |
| Reinforced molecular dynamics: Physics-infused generative machine learning model simulates protein motion. | PNAS Nexus | 2026 | 41522694 | PubTator, text mining | PubMed |
| MDM2 Amplification Enables Selective PROTAC Targeting of Tumor Cells. | Mol Cancer Ther | 2026 | 41517892 | PubTator, text mining | PubMed |
| Unlocking the therapeutic potential of HDAC8-degrading PROTACs: progress, challenges, and future directions. | RSC Med Chem | 2026 | 41497766 | PubTator, text mining | PubMed |
| Iberdomide plus low-dose cyclophosphamide and dexamethasone in patients with relapsed and refractory multiple myeloma (the ICON study): a multicentre, single-arm, phase 2 trial. | Lancet Haematol | 2026 | 41482445 | PubTator, text mining | PubMed |
| Writing the CRBN degron. | Nat Chem Biol | 2026 | 41461924 | PubTator, text mining | PubMed |
| Development of the fluorescence polarization-based competition assay for the E3 ligase GID4. | Bioorg Med Chem Lett | 2026 | 41461350 | PubTator, text mining | PubMed |
| ADSCs-EVs Carrying circITCH Inhibit Pyroptosis of Renal Tubular Epithelial Cells and Alleviate LPS-Induced Acute Kidney Injury. | FASEB J | 2026 | 41445440 | PubTator, text mining | PubMed |
| Direct-to-Biology Enabled Molecular Glue Discovery. | J Am Chem Soc | 2026 | 41443594 | PubTator, text mining | PubMed |
| Synthesis and identification of a novel selective USP7 degrader that inhibits the migration of upper gastrointestinal cancer cells without affecting proliferation. | Eur J Med Chem | 2026 | 41418743 | PubTator, text mining | PubMed |
| Discovery of a dual-target CRBN-mediated degrader for IKZF1/3 and GSPT1 proteins. | Bioorg Chem | 2026 | 41411691 | PubTator, text mining | PubMed |
| A Facile Protocol for C(sp2)-C(sp3) Bond Formation Reactions Toward Functionalized E3 Ligase Ligands. | ChemMedChem | 2026 | 41401975 | PubTator, text mining | PubMed |
| Exposing Hidden Binding Pockets in Cereblon: His378 Conformational Dynamics Inform Novel Ligand Design. | J Phys Chem B | 2026 | 41401814 | PubTator, text mining | PubMed |
| HSP70 Interactome-Mediated Proteolysis Targeting Chimera (HSP70-PROTAC) for Ferroptosis-Driven Cancer Treatment. | Adv Sci (Weinh) | 2026 | 41387312 | PubTator, text mining | PubMed |
| Developmental toxicology profile of the IRAK4 degrader KT-474. | Toxicol Sci | 2026 | 41385308 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of novel PROTACs based on unnatural dipeptide CRBN ligands. | Eur J Med Chem | 2026 | 41313965 | PubTator, text mining | PubMed |
| Discovery of a first-in-class degrader for microphthalmia-associated transcription factor (MITF). | Eur J Med Chem | 2026 | 41259997 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=8